Dalipal Holdings Announces Major Top-Up Placing and Subscription of New Shares

Dalipal Holdings Limited (Stock Code: 1921), a leading player in the oil and gas pipes industry, has announced a significant capital raising exercise through a top-up placing of existing shares and a subscription of new shares under its general mandate. The transaction, involving up to 74,250,000 shares, is set to raise gross proceeds of approximately HK\$392.0 million, with estimated net proceeds of HK\$385.2 million after related costs. This development is likely to have a notable impact on the company’s shareholding structure, capital base, and potentially its share price.

Key Highlights of the Transaction

• Top-Up Placing and Subscription:
  • The Company, the controlling shareholder Rosy Astral Limited (the Vendor), and The Hongkong and Shanghai Banking Corporation Limited (Placing Agent) entered into a Placing and Subscription Agreement on 27 April 2026.
  • Under the agreement, the Placing Agent will, on a best efforts basis, place up to 74,250,000 existing shares held by the Vendor to not less than six independent professional or institutional investors at HK\$5.28 per share—a discount of 12% to the last closing price of HK\$6.00 per share.
  • The Vendor will then subscribe for an equivalent number of new shares at the same price, with shares to be issued under the Company’s General Mandate.
  • Each of the Top-up Placing Shares and Top-up Subscription Shares represents approximately 4.93% of the existing issued share capital and 4.70% of the enlarged share capital post-transaction.
• Shareholding Impact:
  • The Vendor and parties acting in concert with it will see their aggregate shareholding decrease from approximately 46.88% to 41.95% after the placing, and then increase to 44.67% following the subscription.
  • The shareholding structure will be broadened, with the entry of new placees accounting for 4.70% of the enlarged capital base.
• Lock-Up Undertakings:
  • The Vendor has agreed to a 90-day lock-up period post-closing, during which it cannot dispose of, pledge, or otherwise transfer any equity securities of the Company without the Placing Agent’s prior written consent.
  • The Company has also undertaken not to issue or arrange for the placing of any new shares or equity-linked securities during this period, except for shares issued under the current transaction or pursuant to existing share schemes.

Critical Shareholder and Price-Sensitive Information

• Pricing and Dilution:
  • The placing price represents a 12% discount to the prevailing market price, which may impact the short-term share price due to dilution and the introduction of new investors at a lower entry price.
• Regulatory Approvals and Conditions:
  • Completion of the placing and subscription is subject to several conditions, including regulatory approvals, no material adverse market events, and a waiver from the SFC regarding mandatory offer obligations under the Takeovers Code.
  • If the top-up subscription is not completed within 14 days, it will be subject to connected transaction rules, potentially triggering the need for independent shareholder approval.
• Use of Proceeds:
  • The net proceeds of approximately HK\$385.2 million will be used for general working capital and corporate purposes, supporting Dalipal’s 2026 strategic priorities, including R&D investment, expansion in specialty pipes, development of emerging markets, and accelerating its distributed photovoltaic project.
• Application for Listing:
  • An application will be made for the listing and permission to deal in the new shares.
• No Recent Equity Fundraising:
  • This is the first major equity fundraising by Dalipal in the past 12 months, highlighting the significance of this transaction.

Potential Implications for Investors

• This transaction is price-sensitive as it involves a sizeable dilution, placement at a substantial discount, and changes in the shareholding structure. It also signals the company’s intent to pursue growth initiatives and strengthen its balance sheet, which could be positive for long-term value but may result in short-term volatility.
• Investors should monitor the completion of the transaction, regulatory approvals, and the company’s deployment of the raised capital.
• Failure to complete the transaction or material adverse developments could affect the company’s capital position and share price.

Board and Management

• The Vendor, Rosy Astral Limited, is controlled by Mr. Meng Fanyong (Chairman and Executive Director) and Mr. Meng Yuxiang (Executive Director), demonstrating continued commitment and alignment of interests between management and shareholders.
• The Board comprises a mix of executive and independent non-executive Directors, with full responsibility for the accuracy of the disclosed information.

Conclusion

Dalipal’s top-up placing and subscription is a major corporate action, likely to affect its share price and investor sentiment. The transaction will enhance Dalipal’s capital base, support its growth agenda, and diversify its investor profile, but shareholders should be aware of the dilution and potential short-term price pressure arising from the discounted placement.

Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. Investors should conduct their own research or consult a professional adviser before making investment decisions. The information is based on public disclosures by Dalipal Holdings Limited and is subject to change without notice.

View DALIPAL HLDG Historical chart here